Use of fertility treatments in BRCA1/2 mutation carriers and risk for ovarian and breast cancer: a systematic review.

Huber, D; Seitz, S; Kast, K; Emons, G; Ortmann, O

Huber, D; Seitz, S; Kast, K; Emons, G; Ortmann, O.

Affiliation

Huber D; Department of Gynecology and Obstetrics, University Medical Center Regensburg, Regensburg, Germany.
Seitz S; Department of Gynecology and Obstetrics, University Medical Center Regensburg, Regensburg, Germany.
Kast K; Department of Gynecology and Obstetrics, Medical Faculty, University Hospital Carl Gustav Carus, TU Dresden, Dresden, Germany.
Emons G; Department of Gynecology and Obstetrics, Georg August University Göttingen, University Medicine, Göttingen, Germany.
Ortmann O; Department of Gynecology and Obstetrics, University Medical Center Regensburg, Regensburg, Germany. olaf.ortmann@klinik.uni-regensburg.de.

Arch Gynecol Obstet ; 302(3): 715-720, 2020 09.

Article de En | MEDLINE | ID: mdl-32719921

Sujet(s)
Mots clés

BRCA1; BRCA2; Breast cancer; Fertility preservation; Fertility treatment; Ovarian cancer

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Tumeurs de l'ovaire / Tumeurs du sein / Gène BRCA1 / Gène BRCA2 / Préservation de la fertilité Type d'étude: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies / Systematic_reviews Limites: Female / Humans / Middle aged Langue: En Journal: Arch Gynecol Obstet Sujet du journal: GINECOLOGIA / OBSTETRICIA Année: 2020 Type de document: Article Pays d'affiliation: Allemagne Pays de publication: Allemagne

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google